Urologic oncologist Armine Smith, explains our approach to treating bladder cancer as well as the importance of continued research around bladder cancer in women.
During the Johns Hopkins Greenberg Bladder Cancer Institute Grand Rounds in October 2021, Dr. Jean Hoffman-Censits and Dr. Nirmish Singla discuss how doctors get together, go over cases, and share their fields of expertise in bladder and upper tract cancers.
Urologist Nirmish Singla, MD, MSc, discusses kidney health for bladder cancer patients, and how "It's All Related" during the Johns Hopkins Greenberg Bladder Cancer Institute Grand Rounds in February 2022.
Female Reconstructive Urologist Marisa Clifton explains the types of conditions she treats and why specialized care for certain female urologic and pelvic health conditions is important.
Dr. Amend presents background information on the Keystone Cancer Cell, and reviews our current efforts to design treatment strategies that target the unique vulnerabilities of these cells, a theory called evolutionary double bind.
Organ procurement teams are leery of accepting kidneys from deceased donors with acute kidney injury (AKI) fearing they will harm the recipients. However, a national study chaired by a Johns Hopkins kidney specialist suggests these fears may be unfounded.
Alan Partin, M.D., Ph.D., and his research group develop and test blood, urine and tissue cells to detect prostate cancer early.
#TomorrowsDiscoveries: Dr. DeWeese and his team are testing a way to target a protein found on the surface of cancer cells, but not non-cancer cells. Their goal is to destroy cancer while protecting normal tissue.
Urologic oncologist Kenneth Pienta and his team are working to identify what keeps disseminated tumor cells asleep or reactivates them so that they can better treat prostate cancer.
Featured Articles View All »